National Cancer Institute Surveillance, Epidemiology, and End Results Program Cancer Stat Facts: Female Breast Cancer. https://seer.cancer.gov/statfacts/html/breast-subtypes.html. Accessed September 9th, 2023

SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute (2023) Apr 19. [updated: 2023; cited 2023 Sep 9]. https://seer.cancer.gov/statistics-network/explorer/. Data source(s): SEER Incidence Data, November 2022 Submission (1975–2020), SEER 22 registries

Zhang W, Bai Y, Sun C, Lv Z, Wang S (2022) Racial and regional disparities of triple negative breast cancer incidence rates in the United States: an analysis of 2011–2019 NPCR and SEER incidence data. Front Public Health 10:1058722. https://doi.org/10.3389/fpubh.2022.1058722

Article  PubMed  PubMed Central  Google Scholar 

Cho B, Han Y, Lian M, Colditz GA, Weber JD, Ma C, Liu Y (2021) Evaluation of Racial/Ethnic Differences in Treatment and mortality among women with triple-negative breast Cancer. JAMA Oncol 7(7):1016–1023. https://doi.org/10.1001/jamaoncol.2021.1254

Article  PubMed  Google Scholar 

Wang F, Zheng W, Bailey CE, Mayer IA, Pietenpol JA, Shu XO (2021) Racial/Ethnic disparities in all-cause mortality among patients diagnosed with triple-negative breast Cancer. Cancer Res 81(4):1163–1170. https://doi.org/10.1158/0008-5472.CAN-20-3094

Article  CAS  PubMed  Google Scholar 

Ellis L, Canchola AJ, Spiegel D, Ladabaum U, Haile R, Gomez SL (2018) Racial and ethnic disparities in Cancer Survival: the contribution of Tumor, Sociodemographic, Institutional, and Neighborhood characteristics. J Clin Oncol 36(1):25–33. https://doi.org/10.1200/JCO.2017.74.2049

Article  CAS  PubMed  Google Scholar 

Jemal A, Robbins AS, Lin CC, Flanders WD, DeSantis CE, Ward EM, Freedman RA (2018) Factors that contributed to Black-White disparities in Survival among Nonelderly Women with breast Cancer between 2004 and 2013. J Clin Oncol 36(1):14–24. https://doi.org/10.1200/JCO.2017.73.7932

Article  PubMed  Google Scholar 

Prakash O, Hossain F, Danos D, Lassak A, Scribner R, Miele L (2020) Racial disparities in Triple negative breast Cancer: a review of the role of Biologic and non-biologic factors. Front Public Health 8:576964. https://doi.org/10.3389/fpubh.2020.576964

Article  PubMed  PubMed Central  Google Scholar 

Eldridge L, Berrigan D (2022) Structural racism and triple-negative breast Cancer among Black and White women in the United States. Health Equity 6(1):116–123. https://doi.org/10.1089/heq.2021.0041

Article  PubMed  PubMed Central  Google Scholar 

Miller KD, O’Neill A, Gradishar W, Hobday TJ, Goldstein LJ, Mayer IA, Bloom S, Brufsky AM, Tevaarwerk AJ, Sparano JA, Le-Lindqwister NA, Hendricks CB, Northfelt DW, Dang CT, Sledge GW Jr. (2018) Double-blind phase III trial of Adjuvant Chemotherapy with and without Bevacizumab in patients with lymph node-positive and high-risk lymph node-negative breast Cancer (E5103). J Clin Oncol 36(25):2621–2629. https://doi.org/10.1200/JCO.2018.79.2028

Article  CAS  PubMed  PubMed Central  Google Scholar 

Makhani SS, Bouz A, Stavros S, Zucker I, Tercek A, Chung-Bridges K (2022) Racial and ethnic inequality in Survival outcomes of Women with Triple negative breast Cancer. Cureus 14(7):e27120. https://doi.org/10.7759/cureus.27120

Article  PubMed  PubMed Central  Google Scholar 

Oppong BA, Rolle AA, Ndumele A, Li Y, Fisher JL, Bhattacharyya O, Adeyanju T, Paskett ED (2022) Are there differences in outcomes by race among women with metastatic triple-negative breast cancer? Breast Cancer Res Treat 196(2):399–408. https://doi.org/10.1007/s10549-022-06736-8

Article  CAS  PubMed  Google Scholar 

Sung H, Wiese D, Jatoi I, Jemal A (2023) State variation in racial and ethnic disparities in incidence of Triple-negative breast Cancer among US women. JAMA Oncol 9(5):700–704. https://doi.org/10.1001/jamaoncol.2022.7835

Article  PubMed  PubMed Central  Google Scholar 

Michaels EK, Canchola AJ, Beyer KMM, Zhou Y, Shariff-Marco S, Gomez SL (2022) Home mortgage discrimination and incidence of triple-negative and luminal A breast cancer among non-hispanic black and non-hispanic White females in California, 2006–2015. Cancer Causes Control 33(5):727–735. https://doi.org/10.1007/s10552-022-01557-y

Article  PubMed  PubMed Central  Google Scholar 

Vidal G, Bursac Z, Miranda-Carboni G, White-Means S, Starlard-Davenport A (2017) Racial disparities in survival outcomes by breast tumor subtype among African American women in Memphis, Tennessee. Cancer Med 6(7):1776–1786. https://doi.org/10.1002/cam4.1117

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lehrberg A, Davis MB, Baidoun F, Petersen L, Susick L, Jenkins B, Chen Y, Ivanics T, Rakitin I, Bensenhaver J, Proctor E, Nathanson SD, Newman LA (2021) Outcome of African-American compared to White-American patients with early-stage breast cancer, stratified by phenotype. Breast J 27(7):573–580. https://doi.org/10.1111/tbj.14225

Article  PubMed  Google Scholar 

Sarma M, Perimbeti S, Nasir S, Attwood K, Kapoor A, O’Connor T, Early A, Levine EG, Takabe K, Kalinski P, Ambrosone C, Khoury T, Yao S, Gandhi S (2022) Lack of racial differences in clinical outcomes of breast cancer patients receiving neoadjuvant chemotherapy: a single academic center study. Breast Cancer Res Treat 192(2):411–421. https://doi.org/10.1007/s10549-021-06506-y

Article  PubMed  PubMed Central  Google Scholar 

Cherng HR, Rice SR, Hamza M, Murali S, Rosenblatt P, Tkaczuk KHR, Bellavance E, Cheston S, Amin N, Nichols E (2021) Patterns of failure in Triple negative breast Cancer patients in an Urban, Predominately Black Population. J Racial Ethn Health Disparities 8(4):1035–1046. https://doi.org/10.1007/s40615-020-00860-1

Article  PubMed  Google Scholar 

Luo J, Kroenke CH, Hendryx M, Shadyab AH, Liu N, Chen X, Wang F, Thomas F, Saquib N, Qi L, Cheng TD, Arthur R, Wactawski-Wende J (2021) Mediation analysis of racial disparities in triple-negative breast cancer incidence among postmenopausal women. Breast Cancer Res Treat 188(1):283–293. https://doi.org/10.1007/s10549-021-06158-y

Article  PubMed  PubMed Central  Google Scholar 

Linnenbringer E, Geronimus AT, Davis KL, Bound J, Ellis L, Gomez SL (2020) Associations between breast cancer subtype and neighborhood socioeconomic and racial composition among black and white women. Breast Cancer Res Treat 180(2):437–447. https://doi.org/10.1007/s10549-020-05545-1

Article  PubMed  PubMed Central  Google Scholar 

Samiian L, Sharma P, Van Den Bruele AB, Smotherman C, Vincent M, Crandall M (2018) The effect of insurance and race on breast Cancer Tumor Biology and short-term outcomes. Am Surg 84(7):1223–1228

Article  PubMed  Google Scholar 

Zhang L, King J, Wu XC, Hsieh MC, Chen VW, Yu Q, Fontham E, Loch M, Pollack LA, Ferguson T (2019) Racial/ethnic differences in the utilization of chemotherapy among stage I-III breast cancer patients, stratified by subtype: findings from ten National Program of Cancer registries states. Cancer Epidemiol 58:1–7. https://doi.org/10.1016/j.canep.2018.10.015

Article  PubMed  Google Scholar 

Albain KS, Unger JM, Crowley JJ, Coltman CA Jr., Hershman DL (2009) Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst 101(14):984–992. https://doi.org/10.1093/jnci/djp175

Article  PubMed  PubMed Central  Google Scholar 

Albain KS, Gray RJ, Makower DF, Faghih A, Hayes DF, Geyer CE, Dees EC, Goetz MP, Olson JA, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Wood WC, Keane MM, Gomez HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Berenberg JL, Abrams J, Sledge GW, Sparano JA (2021) Race, ethnicity, and clinical outcomes in hormone Receptor-Positive, HER2-Negative, node-negative breast Cancer in the Randomized TAILORx Trial. J Natl Cancer Inst 113(4):390–399. https://doi.org/10.1093/jnci/djaa148

Article  CAS  PubMed  Google Scholar 

Abdou Y, Barlow WE, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF, Lin NU, Perez EA, Goldstein LJ, Chia SK, Dhesy-Thind S, Rastogi P, Alba E, Delaloge S, Schott AF, Shak S, Sharma P, Lew DL, Miao J, Unger JM, Tripathy D, Pusztai L, Hortobagyi GN, Kalinsky K (2023) Abstract GS1-01: Race and clinical outcomes in the RxPONDER Trial (SWOG S1007). Cancer Research 83 (5_Supplement): GS1-01-GS01-01. https://doi.org/10.1158/1538?7445.Sabcs22-gs1-01

Kantor O, King TA, Freedman RA, Mayer EL, Chavez-MacGregor M, Korde LA, Sparano JA, Mittendorf EA (2023) Racial and ethnic disparities in Locoregional recurrence among patients with hormone Receptor-Positive, node-negative breast Cancer: a Post Hoc Analysis of the TAILORx Randomized Clinical Trial. JAMA Surg 158(6):583–591. https://doi.org/10.1001/jamasurg.2023.0297

Article  PubMed  PubMed Central  Google Scholar 

Kim G, Pastoriza JM, Qin J, Lin J, Karagiannis GS, Condeelis JS, Yothers G, Anderson S, Julian T, Entenberg D, Rohan TE, Xue X, Sparano JA, Oktay MH (2022) Racial disparity in distant recurrence-free survival in patients with localized breast cancer: a pooled analysis of National Surgical adjuvant breast and Bowel Project trials. Cancer 128(14):2728–2735. https://doi.org/10.1002/cncr.34241

Article  CAS  PubMed  Google Scholar 

Sparano JA, Wang M, Zhao F, Stearns V, Martino S, Ligibel JA, Perez EA, Saphner T, Wolff AC, Sledge GW Jr., Wood WC, Davidson NE (2012) Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial. J Natl Cancer Inst 104(5):406–414. https://doi.org/10.1093/jnci/djr543

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schneider BP, Shen F, Jiang G, O’Neill A, Radovich M, Li L, Gardner L, Lai D, Foroud T, Sparano JA, Sledge GW Jr., Miller KD (2017) Impact of genetic ancestry on outcomes in ECOG-ACRIN-E5103. JCO Precis Oncol 2017. https://doi.org/10.1200/PO.17.00059

Hershman D, McBride R, Jacobson JS, Lamerato L, Roberts K, Grann VR, Neugut AI (2005) Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol 23(27):6639–6646. https://doi.org/10.1200/JCO.2005.12.633

Article  PubMed  Google Scholar 

Partridge AH, Wang PS, Winer EP, Avorn J (2003) Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 21(4):602–606. https://doi.org/10.1200/JCO.2003.07.071

Article  CAS  PubMed  Google Scholar 

Wheeler SB, Spencer J, Pinheiro LC, Murphy CC, Earp JA, Carey L, Olshan A, Tse CK, Bell ME, Weinberger M, Reeder-Hayes KE (2019) Endocrine therapy nonadherence and discontinuation in Black and White women. J Natl Cancer Inst 111(5):498–508. https://doi.org/10.1093/jnci/djy136

Article  PubMed  Google Scholar 

Rauscher GH, Silva A, Pauls H, Frasor J, Bonini MG, Hoskins K (2017) Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities. Breast Cancer Res Treat 163(2):321–330. https://doi.org/10.1007/s10549-017-4166-z

Article  CAS